Regulus Therapeutics (RGLS) Earnings Date & Reports

Industry: @Pharmaceuticals Other

Get AI intraday signals

A.I. Advisor

published Earnings

RGLS is expected to report earnings to fall 17.95% to -17 cents per share on March 20

Regulus Therapeutics RGLS Stock Earnings Reports

Q4'24

Est.

$-0.17

Q3'24

Missed

by $0.04

Q2'24

Missed

by $0.05

Q1'24

Missed

by $0.07

Q4'23

Est.

$-0.40

The last earnings report on November 07 showed earnings per share of -20 cents, missing the estimate of -17 cents. With 56.61K shares outstanding, the current market capitalization sits at 106.11M.

View a ticker or compare two or three

Compare

RGLS

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For RGLS
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a developer of pharmaceutical products

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Pharmaceuticals Other

Address

4224 Campus Point Court

Phone

+1 858 202-6300

Employees

Web

https://www.regulusrx.com